Absolutely Brilliant ,, Great Find Quiltman , if i could give you more GA I would
Patient Testimonial
“I feel that the monepantel may have slowed my neurological deterioration,” said a MEND participant in the high-dose group. “My dosage was increased to 6 [mg/kg] several days ago. There appears to be no side effects with it.”
from Thurn
To know that we have potentially prolonged the lives of 12 patients [in this trial] is extremely satisfying and humbling.
That is exactly the type of article that was required pre open on the Wednesday the morning after the Positive Phase I Data was announced .Comprehensive and well written engaging Editorial ..
https://alsnewstoday.com/news/vet-drug-monepantel-slows-als-mnd-disease-progression-trial/
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-881
-
- There are more pages in this discussion • 544 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |